Cargando…
Pneumocystis Infection in Two Patients Treated with Both Immune Checkpoint Inhibitor and Corticoids
The introduction of immune checkpoint inhibitor (ICI) targeting cytotoxic T-lymphocyte-associated antigen-4 and programmed cell death receptor 1 has dramatically improved clinical outcome for cancer patients. Nevertheless, this treatment can be associated with immune-related adverse events (irAEs) w...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208388/ https://www.ncbi.nlm.nih.gov/pubmed/35756180 http://dx.doi.org/10.4103/JIPO.JIPO_23_19 |